Advances in Nephrology

Genetic control of renal development; fetal nephron mass: its control and deficit; oligomacronephronic hypoplasia; the fetal origin of hypertension; gene therapy for disease: how might it occur in the kidney? gene therapy in cancer: how can it be applied in renal cell carcinoma; gene therapy of primary immunodeficencies; prospects fro gene therapy of post-angioplasty restenosis; gene transfer for erythropoiesis enhancement; mechanisms causing loss of lean body mass in uremia; uremic toxins; acute kidney rejection; is there a concensus? prolonged islet allograft acceptance in the absence of Il-4 expression; is ochratoxin a nephrotoxic in man; vascular nephropathies and nephrosclerosis: epidemiology and pathophysiology; glomerular changes in normo- and microalbuminuria patients with long-standing insulin-dependent diabetes mellitus; management of extrarenal complication of autosomal dominant polycystic kidney disease; autoantibodies against components of renal basement membrane; anti-nucleosome antibodies and systemic lupus erythematosus; Cd44, a hyaluronan-binding adhesion molecule: expression in normal and diseased kidneys and by cultured mesangial cells.